Schonfeld Strategic Advisors’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-547,207
| Closed | -$1.21M | – | 2213 |
|
|
2025
Q1 | $1.21M | Buy |
547,207
+13,564
| +3% | +$30K | 0.01% | 1096 |
|
|
2024
Q4 | $2.91M | Buy |
533,643
+507,743
| +1,960% | +$2.77M | 0.02% | 647 |
|
|
2024
Q3 | $215K | Buy |
+25,900
| New | +$215K | ﹤0.01% | 1644 |
|
|
2024
Q2 | – | Sell |
-15,796
| Closed | -$137K | – | 2222 |
|
|
2024
Q1 | $137K | Sell |
15,796
-40,304
| -72% | -$349K | ﹤0.01% | 1632 |
|
|
2023
Q4 | $367K | Buy |
+56,100
| New | +$367K | ﹤0.01% | 1292 |
|
|
2023
Q3 | – | Sell |
-11,800
| Closed | -$147K | – | 1925 |
|
|
2023
Q2 | $147K | Buy |
+11,800
| New | +$147K | ﹤0.01% | 1573 |
|
|
2023
Q1 | – | Sell |
-35,528
| Closed | -$508K | – | 2331 |
|
|
2022
Q4 | $508K | Buy |
+35,528
| New | +$508K | ﹤0.01% | 1503 |
|
|
2022
Q2 | – | Sell |
-61,800
| Closed | -$2.18M | – | 2723 |
|
|
2022
Q1 | $2.18M | Sell |
61,800
-7,114
| -10% | -$251K | 0.02% | 652 |
|
|
2021
Q4 | $2.89M | Buy |
68,914
+55,904
| +430% | +$2.34M | 0.03% | 552 |
|
|
2021
Q3 | $639K | Sell |
13,010
-8,221
| -39% | -$404K | 0.01% | 1079 |
|
|
2021
Q2 | $886K | Sell |
21,231
-20,469
| -49% | -$854K | 0.01% | 930 |
|
|
2021
Q1 | $1.49M | Buy |
41,700
+21,005
| +101% | +$749K | 0.02% | 725 |
|
|
2020
Q4 | $580K | Buy |
+20,695
| New | +$580K | 0.01% | 958 |
|